# Oportun Financial Corp: overview

OPRT · Nasdaq · CIK 1538716 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oprt.md) · [Financials](/companies/oprt/financials.md) · [Filings](/companies/oprt/filings.md) · [Insiders](/companies/oprt/insiders.md)

Latest reported revenue: [$5.2m](/filings/0001538716-26-000067.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001538716-26-000067).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [6,346](/filings/0001538716-25-000105.md) | [4,366 d](/filings/0001538716-26-000015.md) | [5,044](/filings/0001538716-26-000039.md) | [4,842](/filings/0001538716-26-000067.md) | [4,929](/filings/0001538716-25-000105.md) | [4,650 d](/filings/0001538716-26-000015.md) | [4,552](/filings/0001538716-26-000039.md) | [5,164](/filings/0001538716-26-000067.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(472.0%)](/filings/0001538716-25-000105.md) | [200.1% d](/filings/0001538716-26-000015.md) | [193.6%](/filings/0001538716-26-000067.md) | [142.0%](/filings/0001538716-26-000067.md) | [105.5%](/filings/0001538716-25-000105.md) | [73.2% d](/filings/0001538716-26-000015.md) | [51.5%](/filings/0001538716-26-000067.md) | [165.3%](/filings/0001538716-26-000067.md) |
| Diluted EPS | $ per share | [(0.75)](/filings/0001538716-25-000105.md) | not reported | [0.21](/filings/0001538716-26-000039.md) | [0.14](/filings/0001538716-26-000067.md) | [0.11](/filings/0001538716-25-000105.md) | not reported | [0.05](/filings/0001538716-26-000039.md) | [0.17](/filings/0001538716-26-000067.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.8](/filings/0001538716-23-000035.md) | [31.2](/filings/0001538716-24-000032.md) | [25.6](/filings/0001538716-25-000013.md) | [22.7](/filings/0001538716-26-000015.md) | [19.5](/filings/0001538716-26-000015.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [5832.0%](/filings/0001538716-23-000035.md) | [(249.3%)](/filings/0001538716-24-000032.md) | [(703.8%)](/filings/0001538716-25-000013.md) | [(347.1%)](/filings/0001538716-26-000015.md) | [129.7%](/filings/0001538716-26-000015.md) |
| Diluted EPS | $ per share | [1.56](/filings/0001538716-23-000035.md) | [(2.37)](/filings/0001538716-24-000032.md) | [(4.88)](/filings/0001538716-25-000013.md) | [(1.95)](/filings/0001538716-26-000015.md) | [0.53](/filings/0001538716-26-000015.md) |
| Free cash flow | $m | [151](/filings/0001538716-23-000035.md) | [242](/filings/0001538716-24-000032.md) | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/oprt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Forager Capital Management, LLC](/funds/1802986.md) | 2026-06-30 | $25.8m | 4,512,045 |  | Added +1,150,319 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $22.2m | 3,893,025 |  | Added +83,113 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $19.2m | 3,370,232 |  | Added +292,572 |
| [FINDELL CAPITAL MANAGEMENT LLC](/funds/1814465.md) | 2026-06-30 | $16.0m | 2,798,300 |  | Added +50,000 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.9m | 1,742,023 |  | Added +113,545 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $9.5m | 1,663,841 |  | Added +300,053 |
| [Long Focus Capital Management, LLC](/funds/1602716.md) | 2026-06-30 | $8.7m | 1,515,777 |  | Unchanged |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $7.3m | 1,286,133 |  | Added +467,846 |
| [Simcoe Capital LLC](/funds/2109203.md) | 2026-06-30 | $6.5m | 1,134,197 |  | Added +131,926 |
| [Meros Investment Management, LP](/funds/1911372.md) | 2026-06-30 | $6.4m | 1,125,231 |  | Added +398,846 |

## Recent filings

[All 741 filings](/companies/oprt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-11 | 16:40 ET | [8-K](/filings/0001538716-26-000101.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001538716-26-000101 |
| 2026-08-25 | 16:45 ET | [8-K](/filings/0001538716-26-000096.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001538716-26-000096 |
| 2026-08-14 | 19:39 ET | [8-K](/filings/0001538716-26-000084.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001538716-26-000084 |
| 2026-08-06 | 19:06 ET | [10-Q](/filings/0001538716-26-000067.md) | Quarterly report, period 2026-06-30 | 0001538716-26-000067 |
| 2026-08-05 | 16:19 ET | [8-K](/filings/0001538716-26-000065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001538716-26-000065 |
| 2026-07-07 | 17:03 ET | [8-K](/filings/0001538716-26-000060.md) | 1.01 Entry into a material agreement | 0001538716-26-000060 |
| 2026-06-29 | 17:21 ET | [DEF 14A](/filings/0001140361-26-026773.md) | Proxy statement, period 2026-08-11 | 0001140361-26-026773 |
| 2026-06-24 | 08:30 ET | [8-K](/filings/0001538716-26-000052.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001538716-26-000052 |
| 2026-06-18 | 16:25 ET | [8-K](/filings/0001193125-26-275929.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-275929 |
| 2026-05-08 | 07:18 ET | [10-Q](/filings/0001538716-26-000039.md) | Quarterly report, period 2026-03-31 | 0001538716-26-000039 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001538716-26-000015.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/870a7550-65c6-453e-b226-a2d295854214)

## About the filer

- CIK: 1538716
- Tickers: OPRT
- Exchange: Nasdaq
- SIC code: 6199 Finance Services
- State of incorporation: DE
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.
